tradingkey.logo

Anbio Biotechnology

NNNN
查看详细走势图
25.650USD
+1.590+6.61%
收盘 02/06, 16:00美东报价延迟15分钟
1.13B总市值
416.53市盈率 TTM

Anbio Biotechnology

25.650
+1.590+6.61%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+6.61%

5天

+17.07%

1月

-25.11%

6月

-44.30%

今年开始到现在

-14.70%

1年

0.00%

查看详细走势图

TradingKey股票评分

由于缺少必要的数据,暂不能对该公司进行评分

Anbio Biotechnology新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Anbio Biotechnology简介

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
公司代码NNNN
公司Anbio Biotechnology
CEOLau (Michael)
网址https://anbiobiotechnology.com/
KeyAI